SCHEMBL720662

SCHEMBL720662

C=C(CCCCCC)C(=O)NCC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.59
CES2 O00748 3/20 0.46
CES1 P23141 3/20 0.46
PLA2G2A P14555 1/20 0.46
HSP90AA1 P07900 1/20 0.45
GPR84 Q9NQS5 7/20 0.45
PPARG P37231 7/20 0.45
PPARD Q03181 7/20 0.45
PPARA Q07869 7/20 0.45
HDAC11 Q96DB2 5/20 0.45
TSHR P16473 4/20 0.45
PTPN1 P18031 3/20 0.45
ALDH1A1 P00352 2/20 0.45
TLR2 O60603 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
FABP4 P15090 2/20 0.45
SLC22A6 Q4U2R8 1/20 0.45
SLC22A8 Q8TCC7 1/20 0.45
MEN1 O00255 1/20 0.45
ESR1 P03372 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28890853 0.92 FAAH (0.47) FAAHCES2CES1PLA2G2AALDH1A1
SCHEMBL2811298 0.87 FAAH (0.40) FAAHPLA2G2AHDAC11TSHRALDH1A1
SCHEMBL7161002 0.86 PLA2G2A (0.59) FAAHPLA2G2A
SCHEMBL12256836 0.83 PLA2G2A (0.69) FAAHPLA2G2AGPR84PPARGPPARD
SCHEMBL20379712 0.83 FAAH (0.40) FAAHCES2CES1PLA2G2ATSHR
SCHEMBL4754540 0.82 CES2 (0.48) FAAHCES2CES1HSP90AA1GPR84
SCHEMBL8085527 0.82 HSP90AA1 (0.57) FAAHCES2CES1HSP90AA1GPR84
SCHEMBL454724 0.80 FAAH (0.42) FAAHCES2CES1PLA2G2AHSP90AA1
SCHEMBL11238049 0.80 FAAH (0.35) FAAHPLA2G2AHDAC11ALOX15KMT2A
SCHEMBL5693537 0.80 CYP1A2 (0.39) FAAHHDAC11TSHRALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 213 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022235555-A1 BLOCK COPOLYMERS DERIVED FROM SHORT AND LONG ALKYL CHAIN ACRYLATES OR ACRYLAMIDES AND APPLICATIONS THEREOF ISP INVESTMENTS LLC (US) 2022-11-10 WO claimed
US-20150159009-A1 GRAFT COPOLYMERS, THEIR PREPARATION AND USE IN CAPILLARY ELECTROPHORESIS APPLIED BIOSYSTEMS LLC (US) 2015-06-11 US claimed
US-20130153421-A1 GRAFT COPOLYMERS, THEIR PREPARATION AND USE IN CAPILLARY ELECTROPHORESIS APPLIED BIOSYSTEMS, LLC (US) 2013-06-20 US claimed
EP-2275463-A1 Support for electrophoresis containing a composition and method Life Technologies Corporation (US) 2011-01-19 EP claimed
EP-1539846-B1 GRAFT COPOLYMERS, THEIR PREPARATION AND USE IN CAPILLARY ELECTROPHORESIS LIFE TECHNOLOGIES CORP (US) 2010-09-08 EP claimed
EP-1266914-B1 Flow-and-levelling agents for waterborne coatings KUSUMOTO CHEMICALS (JP) 2006-08-02 EP claimed
US-20050234166-A1 Graft copolymers, their preparation and use in capillary electrophoresis APPLIED BIOSYSTEMS, INC. 2005-10-20 US claimed
EP-1539846-A1 GRAFT COPOLYMERS, THEIR PREPARATION AND USE IN CAPILLARY ELECTROPHORESIS Applera Corporation (US) 2005-06-15 EP claimed
US-20040097652-A1 Flow-and-leveling agents for waterborne coatings KAWASE MASAFUMI (JP) 2004-05-20 US claimed
WO-2004011513-A1 GRAFT COPOLYMERS, THEIR PREPARATION AND USE IN CAPILLARY ELECTROPHORESIS APPLERA CORPORATION (US) 2004-02-05 WO claimed
US-20030105228-A1 Flow-and-leveling agents for waterborne coatings KUSUMOTO CHEMICALS, LTD. 2003-06-05 US claimed
US-6497867-B2 USING COPOLYMER IN PHARMACEUTICAL AND COSMETIC PREPARATIONS BASF AKTIENGESELLSCHAFT (DE) 2002-12-24 US claimed
EP-1266914-A1 Flow-and-leveling agents for waterborne coatings Kusumoto Chemicals, Ltd. (JP) 2002-12-18 EP claimed
US-6331294-B1 FOR HOMOGENEOUS PHARMACEUTICAL OR COSMETIC PREPARATIONS, BASF AKTIENGESELLSCHAFT (DE) 2001-12-18 US claimed
US-12528964-B2 Aqueous dispersion comprising multistage polymeric particles DOW GLOBAL TECHNOLOGIES LLC (US) 2026-01-20 US disclosed
US-12503540-B2 Aqueous dispersion of polymer additive and process for preparing the same DOW GLOBAL TECHNOLOGIES LLC (US) 2025-12-23 US disclosed
US-12371515-B2 Multistage emulsion polymer and process of preparing the same DOW GLOBAL TECHNOLOGIES LLC (US) 2025-07-29 US disclosed
US-4121032-A Process for preparing alternating copolymer of conjugated vinyl compound and olefinic unsaturated compound with oxygen and boron compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1978-10-17 US disclosed
US-4028431-A ETHYLENE-HEXAFLUOROPROPYLENE POLYMER, SILICONE RUBBERS, AND VINYLIDENE FLUORIDE COPOLYMER DAIKIN KOGYO CO., LTD. (JA) 1977-06-07 US disclosed
US-3989882-A Process for preparing an alternating copolymer of a conjugated vinyl compound and an olefinic unsaturated compound SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1976-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12528964-B2 Aqueous dispersion comprising multistage polymeric particles CLTB, MSR1, TAF1 FAAH 4056/4885CES2 1420/4885CES1 2604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.